Efficacy of Intravenous Gamma Globulin on Guillain-Barre Syndrome

Clinical trial NCT04303962 · UNKNOWN

Trial details

NCT number: NCT04303962
Sponsor: Ning Wang, MD., PhD.
Status: UNKNOWN
Study type: OBSERVATIONAL

Guillain-barre Syndrome

Start date: 2020-04-27
Primary completion: 2024-01-21
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.